Use of artifact-centric development approaches has doubled in past two years
This year’s results show the number of respondents using artifact-centric approaches has doubled over the past two years, indicating a trend away from document-centric methods. However, a majority of medical device companies still rely on documents for traceability, risk mitigation, and other key processes—which clouds visibility into project status, complicates design transfers between teams, and hinders accountability.
Other key findings include significant changes in the way medical device developers manage risk, requirements, and core artifacts. The changes allow them to better focus on the artifacts they need to track to assure product quality and more effectively mitigate risk. For risk management alone, survey results show a 500 percent increase in the use of commercial software tools since 2011.
Participants also identified where their product development processes are weak, and the barriers that keep them from improving those processes. Nearly 60 percent indicated the same non-productive chore—documenting work—as one of their most time-consuming tasks, taking valuable hours or even days away from more productive work.
After analyzing data from both the 2011 and this year’s surveys, Seapine’s industry experts estimate between 60 to 80 percent of medical device companies will adopt artifact-centric processes by 2015.
With more than 8,500 customers worldwide,
Most Popular Stories
- SpaceX's Satellite Launch Is 'Game-Changer'
- Maui Visitor Killed in Shark Attack
- Brazil Braces for Street Protests at World Cup
- Sprint Not Moving Headquarters to California
- Reid Confident Congress to Pass Immigration Bill
- Donors Abandon GOP Over Gun Stance
- Boehner Hires Immigration Reform Expert
- Wisconsin Gov. Campaign Aide Fired Over Tweets
- Gloom Settles on Markets Despite Strong Jobs Report
- Healthcare.gov Update Gets Mixed Reviews